<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37577373</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>MicroRNA expression profile of human umbilical vein endothelial cells in response to coxsackievirus A10 infection reveals a potential role of miR-143-3p in maintaining the integrity of the blood-brain barrier.</ArticleTitle><Pagination><StartPage>1217984</StartPage><MedlinePgn>1217984</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1217984</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2023.1217984</ELocationID><Abstract><AbstractText>Coxsackievirus A10 (CV-A10) has been one of the main etiologies of hand, foot, and mouth disease (HFMD) epidemics in recent years and can cause mild to severe illness and even death. Most of these severe and fatal cases were closely associated with neurological impairments, but the potential mechanism of neuropathological injury triggered by CV-A10 infection has not been elucidated. MicroRNAs (miRNAs), implicated in the regulation of gene expression in a post-transcriptional manner, play a vital role in the pathogenesis of various central nervous system (CNS) diseases; therefore, they serve as diagnostic biomarkers and are emerging as novel therapeutic targets for CNS injuries. To gain insights into the CV-A10-induced regulation of host miRNA-processing machinery, we employed high-throughput sequencing to identify differentially expressed miRNAs in CV-A10-infected human umbilical vein endothelial cells (HUVECs) and further analyzed the potential functions of these miRNAs during CV-A10 infection. The results showed that CV-A10 infection could induce 189 and 302 significantly differentially expressed miRNAs in HUVECs at 24 and 72 hpi, respectively, compared with the uninfected control. Moreover, the expression of four selected miRNAs and their relevant mRNAs was determined to verify the sequencing data by quantitative reverse transcription-polymerase chain reaction (RT-qPCR) methods. After that, gene target prediction and functional annotation revealed that the targets of these dysregulated miRNAs were mostly enriched in cell proliferation, signal transduction, cAMP signalling pathway, cellular response to interleukin-6, ventral spinal cord interneuron differentiation, negative regulation of glial cell differentiation, neuron migration, positive regulation of neuron projection development, etc., which were primarily involved in the processes of basic physiology, host immunity, and neurological impairments and further reflected vital regulatory roles of miRNA in viral pathogenicity. Finally, the construction of a miRNA-regulated network also suggested that the complex regulatory mechanisms mediated by miRNAs might be involved in viral pathogenesis and virus-host interactions during CV-A10 infection. Furthermore, among these dysregulated miRNAs, miR-143-3p was demonstrated to be involved in the maintenance of blood-brain barrier (BBB) integrity.</AbstractText><CopyrightInformation>Copyright © 2023 Hu, Cui, Wang, Liu, Zhang, Wang, Song and Zhang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yajie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yunnan Provincial Key Laboratory of Clinical Virology, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Fengxian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Thoracic Surgery, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shenglan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shengxiong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ruiqi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Medical Biology, Chinese Academy of Medical Science and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yunhui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pulmonary and Critical Care Medicine, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>16VY3TM7ZO</RegistryNumber><NameOfSubstance UI="C052091">antineoplaston A10</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C542359">MIRN143 microRNA, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061307" MajorTopicYN="N">Human Umbilical Vein Endothelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="Y">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">and mouth disease (HFMD)</Keyword><Keyword MajorTopicYN="N">blood–brain barrier (BBB)</Keyword><Keyword MajorTopicYN="N">coxsackievirus A10 (CV-A10)</Keyword><Keyword MajorTopicYN="N">foot</Keyword><Keyword MajorTopicYN="N">hand</Keyword><Keyword MajorTopicYN="N">high-throughput sequencing</Keyword><Keyword MajorTopicYN="N">microRNAs (miRNAs)</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>4</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37577373</ArticleId><ArticleId IdType="pmc">PMC10419304</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2023.1217984</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abbott N. J., Patabendige A. A., Dolman D. E., Yusof S. R., Begley D. J. (2010). Structure and function of the blood-brain barrier. Neurobiol. Dis. 37 (1), 13–25. doi: 10.1016/j.nbd.2009.07.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.07.030</ArticleId><ArticleId IdType="pubmed">19664713</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Obaidi M. M. J., Bahadoran A., Wang S. M., Manikam R., Raju C. S., Sekaran S. D. (2018). Disruption of the blood brain barrier is vital property of neurotropic viral infection of the central nervous system. Acta Virol. 62 (1), 16–27. doi: 10.4149/av_2018_102</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/av_2018_102</ArticleId><ArticleId IdType="pubmed">29521099</ArticleId></ArticleIdList></Reference><Reference><Citation>An X., Ge J., Guo H., Mi H., Zhou J., Liu Y., et al. . (2019). Overexpression of miR-4286 is an unfavorable prognostic marker in individuals with non-small cell lung cancer. J. Cell Biochem. 120 (10), 17573–17583. doi: 10.1002/jcb.29024</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.29024</ArticleId><ArticleId IdType="pubmed">31111550</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf U., Ding Z., Deng S., Ye J., Cao S., Chen Z. (2021). Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage. Virulence 12 (1), 968–980. doi: 10.1080/21505594.2021.1899674</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2021.1899674</ArticleId><ArticleId IdType="pmc">PMC7971234</ArticleId><ArticleId IdType="pubmed">33724154</ArticleId></ArticleIdList></Reference><Reference><Citation>Aswathyraj S., Arunkumar G., Alidjinou E. K., Hober D. (2016). Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy. Med. Microbiol. Immunol. 205 (5), 397–407. doi: 10.1007/s00430-016-0465-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-016-0465-y</ArticleId><ArticleId IdType="pubmed">27406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Backes C., Meese E., Keller A. (2016). Specific miRNA disease biomarkers in blood, serum and plasma: challenges and prospects. Mol. Diagn. Ther. 20 (6), 509–518. doi: 10.1007/s40291-016-0221-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40291-016-0221-4</ArticleId><ArticleId IdType="pubmed">27378479</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y., Zhang Y., Han B., Yang L., Chen X., Huang R., et al. . (2018). Circular RNA DLGAP4 ameliorates ischemic stroke outcomes by targeting miR-143 to regulate endothelial-mesenchymal transition associated with blood-brain barrier integrity. J. Neurosci. 38 (1), 32–50. doi: 10.1523/JNEUROSCI.1348-17.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1348-17.2017</ArticleId><ArticleId IdType="pmc">PMC6705810</ArticleId><ArticleId IdType="pubmed">29114076</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y., Zhang Y., Hua J., Yang X., Zhang X., Duan M., et al. . (2016). Silencing microRNA-143 protects the integrity of the blood-brain barrier: implications for methamphetamine abuse. Sci. Rep. 6, 35642. doi: 10.1038/srep35642</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep35642</ArticleId><ArticleId IdType="pmc">PMC5073292</ArticleId><ArticleId IdType="pubmed">27767041</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian L., Gao F., Mao Q., Sun S., Wu X., Liu S., et al. . (2019). Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems. Expert Rev. Anti Infect. Ther. 17 (4), 233–242. doi: 10.1080/14787210.2019.1585242</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2019.1585242</ArticleId><ArticleId IdType="pubmed">30793637</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y., Yu X., Hu S., Yu J. (2009). A brief review on the mechanisms of miRNA regulation. Genomics Proteomics Bioinf. 7 (4), 147–154. doi: 10.1016/S1672-0229(08)60044-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1672-0229(08)60044-3</ArticleId><ArticleId IdType="pmc">PMC5054406</ArticleId><ArticleId IdType="pubmed">20172487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y. K., Chen K. H., Chen K. T. (2018). Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development. Rev. Inst Med. Trop. Sao Paulo 60, e70. doi: 10.1590/S1678-9946201860070</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S1678-9946201860070</ArticleId><ArticleId IdType="pmc">PMC6223252</ArticleId><ArticleId IdType="pubmed">30427405</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K. K., Minakuchi M., Wuputra K., Ku C. C., Pan J. B., Kuo K. K., et al. . (2020). Redox control in the pathophysiology of influenza virus infection. BMC Microbiol. 20 (1), 214. doi: 10.1186/s12866-020-01890-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-020-01890-9</ArticleId><ArticleId IdType="pmc">PMC7370268</ArticleId><ArticleId IdType="pubmed">32689931</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiaretti A., Pulitano S., Barone G., Ferrara P., Romano V., Capozzi D., et al. . (2013). IL-1 beta and IL-6 upregulation in children with H1N1 influenza virus infection. Mediators Inflammation 2013, 495848. doi: 10.1155/2013/495848</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/495848</ArticleId><ArticleId IdType="pmc">PMC3657430</ArticleId><ArticleId IdType="pubmed">23737648</ArticleId></ArticleIdList></Reference><Reference><Citation>Choy E. H., De Benedetti F., Takeuchi T., Hashizume M., John M. R., Kishimoto T. (2020). Translating IL-6 biology into effective treatments. Nat. Rev. Rheumatol 16 (6), 335–345. doi: 10.1038/s41584-020-0419-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0419-z</ArticleId><ArticleId IdType="pmc">PMC7178926</ArticleId><ArticleId IdType="pubmed">32327746</ArticleId></ArticleIdList></Reference><Reference><Citation>Coomes E. A., Haghbayan H. (2020). Interleukin-6 in Covid-19: A systematic review and meta-analysis. Rev. Med. Virol. 30 (6), 1–9. doi: 10.1002/rmv.2141</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2141</ArticleId><ArticleId IdType="pmc">PMC7460877</ArticleId><ArticleId IdType="pubmed">32845568</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding R., Qu Y., Wu C. H., Vijay-Shanker K. (2018). Automatic gene annotation using GO terms from cellular component domain. BMC Med. Inform Decis Mak 18 (Suppl 5), 119. doi: 10.1186/s12911-018-0694-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-018-0694-7</ArticleId><ArticleId IdType="pmc">PMC6284271</ArticleId><ArticleId IdType="pubmed">30526566</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan X., Chen Z., Li X., Yuan P., Long L. (2021). Virus shedding in patients with hand, foot and mouth disease induced by EV71, CA16 or CA6: systematic review and meta-analysis. Pediatr. Infect. Dis. J. 40 (4), 289–294. doi: 10.1097/INF.0000000000002985</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002985</ArticleId><ArticleId IdType="pubmed">33181780</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan X., Wang L., Sun G., Yan W., Yang Y. (2020). Understanding the cross-talk between host and virus in poultry from the perspectives of microRNA. Poult Sci. 99 (4), 1838–1846. doi: 10.1016/j.psj.2019.11.053</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psj.2019.11.053</ArticleId><ArticleId IdType="pmc">PMC7587795</ArticleId><ArticleId IdType="pubmed">32241464</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelmann I., Alidjinou E. K., Bertin A., Sane F., Hober D. (2018). miRNAs in enterovirus infection. Crit. Rev. Microbiol. 44 (6), 701–714. doi: 10.1080/1040841X.2018.1499608</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1040841X.2018.1499608</ArticleId><ArticleId IdType="pubmed">30106324</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S., Principi N. (2018). Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur. J. Clin. Microbiol. Infect. Dis. 37 (3), 391–398. doi: 10.1007/s10096-018-3206-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-018-3206-x</ArticleId><ArticleId IdType="pubmed">29411190</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang C. Y., Liu C. C. (2018). Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease. Expert Rev. Vaccines 17 (9), 819–831. doi: 10.1080/14760584.2018.1510326</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2018.1510326</ArticleId><ArticleId IdType="pubmed">30095317</ArticleId></ArticleIdList></Reference><Reference><Citation>Filatova E. N., Sakharnov N. A., Knyazev D. I., Utkin O. V. (2019). Changes in mRNA expression of members of TGFB1-associated pathways in human leukocytes during EBV infection. Acta Microbiol. Immunol. Hung 66 (2), 247–254. doi: 10.1556/030.65.2018.047</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/030.65.2018.047</ArticleId><ArticleId IdType="pubmed">30465450</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y., Xu W., Chen D., Feng C., Zhang L., Wang X., et al. . (2015). Enterovirus 71 induces autophagy by regulating has-miR-30a expression to promote viral replication. Antiviral Res. 124, 43–53. doi: 10.1016/j.antiviral.2015.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.09.016</ArticleId><ArticleId IdType="pubmed">26515789</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez G., Carr M. J., Kobayashi M., Hanaoka N., Fujimoto T. (2019). Enterovirus-associated hand-foot and mouth disease and neurological complications in Japan and the rest of the world. Int. J. Mol. Sci. 20 (20), 5201. doi: 10.3390/ijms20205201</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205201</ArticleId><ArticleId IdType="pmc">PMC6834195</ArticleId><ArticleId IdType="pubmed">31635198</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Song J., Liu L., Li J., Tang B., Zhang Y., et al. . (2017). Comparison analysis of microRNAs in response to EV71 and CA16 infection in human bronchial epithelial cells by high-throughput sequencing to reveal differential infective mechanisms. Virus Res. 228, 90–101. doi: 10.1016/j.virusres.2016.11.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2016.11.024</ArticleId><ArticleId IdType="pubmed">27890633</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Song J., Liu L., Zhang Y., Wang L., Li Q. (2018). microRNA-4516 contributes to different functions of epithelial permeability barrier by targeting poliovirus receptor related protein 1 in enterovirus 71 and coxsackievirus A16 infections. Front. Cell Infect. Microbiol. 8. doi: 10.3389/fcimb.2018.00110</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2018.00110</ArticleId><ArticleId IdType="pmc">PMC5900049</ArticleId><ArticleId IdType="pubmed">29686973</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M., Furumichi M., Tanabe M., Sato Y., Morishima K. (2017). KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45 (D1), D353–D361. doi: 10.1093/nar/gkw1092</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1092</ArticleId><ArticleId IdType="pmc">PMC5210567</ArticleId><ArticleId IdType="pubmed">27899662</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimmis B. D., Downing C., Tyring S. (2018). Hand-foot-and-mouth disease caused by coxsackievirus A6 on the rise. Cutis 102 (5), 353–356.</Citation><ArticleIdList><ArticleId IdType="pubmed">30566537</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Zhao S., Wang H., Zhang B., Zhang P. (2019). miR-4286 promotes prostate cancer progression via targeting the expression of SALL1. J. Gene Med. 25 (7), e3127. doi: 10.1002/jgm.3127</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jgm.3127</ArticleId><ArticleId IdType="pubmed">31693770</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Li M., Zhou Z., Guan X., Xiang Y. (2020). Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)? J. Autoimmun 111, 102452. doi: 10.1016/j.jaut.2020.102452</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102452</ArticleId><ArticleId IdType="pmc">PMC7151347</ArticleId><ArticleId IdType="pubmed">32291137</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Song Y. Y., Wang J. Y., Xiao H., Zhang Y., Luo B. (2020). Dysregulation of FOXO transcription factors in Epstein-Barr virus-associated gastric carcinoma. Virus Res. 276, 197808. doi: 10.1016/j.virusres.2019.197808</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2019.197808</ArticleId><ArticleId IdType="pubmed">31712122</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z., Su R., Wang W., Liang Y., Zeng X., Shereen M. A., et al. . (2019). EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production. PloS Pathog. 15 (11), e1008142. doi: 10.1371/journal.ppat.1008142</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008142</ArticleId><ArticleId IdType="pmc">PMC6932824</ArticleId><ArticleId IdType="pubmed">31730654</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q. Y., Wang Y., Bian L., Xu M., Liang Z. (2016). EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev. Vaccines 15 (5), 599–606. doi: 10.1586/14760584.2016.1138862</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2016.1138862</ArticleId><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunshola O. O. (2011). In vitro modeling of the blood-brain barrier: simplicity versus complexity. Curr. Pharm. Des. 17 (26), 2755–2761. doi: 10.2174/138161211797440159</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161211797440159</ArticleId><ArticleId IdType="pubmed">21827410</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono C., Fukuhara T., Li S., Wang J., Sato A., Izumi T., et al. . (2020). Various miRNAs compensate the role of miR-122 on HCV replication. PloS Pathog. 16 (6), e1008308. doi: 10.1371/journal.ppat.1008308</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008308</ArticleId><ArticleId IdType="pmc">PMC7337399</ArticleId><ArticleId IdType="pubmed">32574204</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka M., Jing Q., Georgel P., New L., Chen J., Mols J., et al. . (2007). Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 27 (1), 123–134. doi: 10.1016/j.immuni.2007.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2007.05.014</ArticleId><ArticleId IdType="pubmed">17613256</ArticleId></ArticleIdList></Reference><Reference><Citation>Oura K., Morishita A., Masaki T. (2020). Molecular and functional roles of microRNAs in the progression of hepatocellular carcinoma-A review. Int. J. Mol. Sci. 21 (21), 8362. doi: 10.3390/ijms21218362</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218362</ArticleId><ArticleId IdType="pmc">PMC7664704</ArticleId><ArticleId IdType="pubmed">33171811</ArticleId></ArticleIdList></Reference><Reference><Citation>Pritchard C. C., Cheng H. H., Tewari M. (2012). MicroRNA profiling: approaches and considerations. Nat. Rev. Genet. 13 (5), 358–369. doi: 10.1038/nrg3198</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg3198</ArticleId><ArticleId IdType="pmc">PMC4517822</ArticleId><ArticleId IdType="pubmed">22510765</ArticleId></ArticleIdList></Reference><Reference><Citation>Saguil A., Kane S. F., Lauters R., Mercado M. G. (2019). Hand-foot-and-mouth disease: rapid evidence review. Am. Fam Physician 100 (7), 408–414.</Citation><ArticleIdList><ArticleId IdType="pubmed">31573162</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedger L. M. (2013). microRNA control of interferons and interferon induced anti-viral activity. Mol. Immunol. 56 (4), 781–793. doi: 10.1016/j.molimm.2013.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2013.07.009</ArticleId><ArticleId IdType="pubmed">23962477</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Balakathiresan N. S., Maheshwari R. K. (2015). Chikungunya virus infection alters expression of microRNAs involved in cellular proliferation, immune response and apoptosis. Intervirology 58 (5), 332–341. doi: 10.1159/000441309</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000441309</ArticleId><ArticleId IdType="pubmed">26829480</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Hu Y., Jiang X., Zhu W., Wu Z., Dong S. (2018. a). Profiling of novel microRNAs elicited by EV71 and CA16 infection in human bronchial epithelial cells using high-throughput sequencing. Virus Res. 247, 111–119. doi: 10.1016/j.virusres.2018.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2018.02.008</ArticleId><ArticleId IdType="pubmed">29447975</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Hu Y., Li H., Huang X., Zheng H., Wang J., et al. . (2018. b). miR-1303 regulates BBB permeability and promotes CNS lesions following CA16 infections by directly targeting MMP9. Emerg. Microbes Infect. 7 (1), 155. doi: 10.1038/s41426-018-0157-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41426-018-0157-3</ArticleId><ArticleId IdType="pmc">PMC6143596</ArticleId><ArticleId IdType="pubmed">30228270</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Hu Y., Li J., Zheng H., Wang J., Guo L., et al. . (2017). Different microRNA profiles reveal the diverse outcomes induced by EV71 and CA16 infection in human umbilical vein endothelial cells using high-throughput sequencing. PloS One 12 (5), e0177657. doi: 10.1371/journal.pone.0177657</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177657</ArticleId><ArticleId IdType="pmc">PMC5439704</ArticleId><ArticleId IdType="pubmed">28531227</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Hu Y., Zheng H., Guo L., Huang X., Jiang X., et al. . (2019). Comparative analysis of putative novel microRNA expression profiles induced by enterovirus 71 and coxsackievirus A16 infections in human umbilical vein endothelial cells using high-throughput sequencing. Infect. Genet. Evol. 73, 401–410. doi: 10.1016/j.meegid.2019.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2019.06.007</ArticleId><ArticleId IdType="pubmed">31176031</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Jiang X., Hu Y., Li H., Zhang X., Xu J., et al. . (2018. c). High-Throughput Sequencing of Putative Novel microRNAs in Rhesus Monkey Peripheral Blood Mononuclear Cells following EV71 and CA16 Infection. Intervirology 61 (3), 133–142. doi: 10.1159/000493798</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000493798</ArticleId><ArticleId IdType="pubmed">30404089</ArticleId></ArticleIdList></Reference><Reference><Citation>Srisuttee R., Koh S. S., Park E. H., Cho I. R., Min H. J., Jhun B. H., et al. . (2011). Up-regulation of Foxo4 mediated by hepatitis B virus X protein confers resistance to oxidative stress-induced cell death. Int. J. Mol. Med. 28 (2), 255–260. doi: 10.3892/ijmm.2011.699</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2011.699</ArticleId><ArticleId IdType="pubmed">21567078</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B., Yang X., Hou F., Yu X., Wang Q., Oh H. S., et al. . (2021). Regulation of host and virus genes by neuronal miR-138 favours herpes simplex virus 1 latency. Nat. Microbiol. 6 (5), 682–696. doi: 10.1038/s41564-020-00860-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-00860-1</ArticleId><ArticleId IdType="pmc">PMC8221016</ArticleId><ArticleId IdType="pubmed">33558653</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo W. H., Chen H. P., Huang J. C., Chan Y. J. (2017). Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells. Int. J. Oncol. 51 (5), 1415–1426. doi: 10.3892/ijo.2017.4135</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijo.2017.4135</ArticleId><ArticleId IdType="pmc">PMC5642395</ArticleId><ArticleId IdType="pubmed">29048611</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiedt S., Prestel M., Malik R., Schieferdecker N., Duering M., Kautzky V., et al. . (2017). RNA-Seq Identifies Circulating miR-125a-5p, miR-125b-5p, and miR-143-3p as Potential Biomarkers for Acute Ischemic Stroke. Circ. Res. 121 (8), 970–980. doi: 10.1161/CIRCRESAHA.117.311572</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.311572</ArticleId><ArticleId IdType="pubmed">28724745</ArticleId></ArticleIdList></Reference><Reference><Citation>Trobaugh D. W., Klimstra W. B. (2017). MicroRNA regulation of RNA virus replication and pathogenesis. Trends Mol. Med. 23 (1), 80–93. doi: 10.1016/j.molmed.2016.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2016.11.003</ArticleId><ArticleId IdType="pmc">PMC5836316</ArticleId><ArticleId IdType="pubmed">27989642</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C. C., Chen T. Y., Tsai K. J., Lin M. W., Hsu C. Y., Wu D. C., et al. . (2020). NF-kappaB/miR-18a-3p and miR-4286/BZRAP1 axis may mediate carcinogenesis in Helicobacter pylori-Associated gastric cancer. BioMed. Pharmacother. 132, 110869. doi: 10.1016/j.biopha.2020.110869</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110869</ArticleId><ArticleId IdType="pubmed">33113427</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu Z., Xu M., Zhang J., Feng Y., Hao Z., Tu C., et al. . (2019). Pentagalloylglucose Inhibits the Replication of Rabies Virus via Mediation of the miR-455/SOCS3/STAT3/IL-6 Pathway. J. Virol. 93 (18), e00539–19. doi: 10.1128/JVI.00539-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00539-19</ArticleId><ArticleId IdType="pmc">PMC6714789</ArticleId><ArticleId IdType="pubmed">31243136</ArticleId></ArticleIdList></Reference><Reference><Citation>Untucht C., Rasch J., Fuchs E., Rohde M., Bergmann S., Steinert M. (2011). An optimized in vitro blood-brain barrier model reveals bidirectional transmigration of African trypanosome strains. Microbiol. (Reading) 157 (Pt 10), 2933–2941. doi: 10.1099/mic.0.049106-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/mic.0.049106-0</ArticleId><ArticleId IdType="pubmed">21737496</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz de Paula C. B., Nagashima S., Liberalesso V., Collete M., da Silva F. P. G., Oricil A. G. G., et al. . (2021). COVID-19: immunohistochemical analysis of TGF-beta signaling pathways in pulmonary fibrosis. Int. J. Mol. Sci. 23 (1), 168. doi: 10.3390/ijms23010168</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23010168</ArticleId><ArticleId IdType="pmc">PMC8745764</ArticleId><ArticleId IdType="pubmed">35008594</ArticleId></ArticleIdList></Reference><Reference><Citation>Vittor A. Y., Long M., Chakrabarty P., Aycock L., Kollu V., DeKosky S. T. (2020). West nile virus-induced neurologic sequelae-relationship to neurodegenerative cascades and dementias. Curr. Trop. Med. Rep. 7 (1), 25–36. doi: 10.1007/s40475-020-00200-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40475-020-00200-7</ArticleId><ArticleId IdType="pmc">PMC7409821</ArticleId><ArticleId IdType="pubmed">32775145</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Xu F., Zhu X., Li X., Li Y., Li J. (2021). Targeting microRNAs to regulate the integrity of the blood-brain barrier. Front. Bioeng Biotechnol. 9. doi: 10.3389/fbioe.2021.673415</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2021.673415</ArticleId><ArticleId IdType="pmc">PMC8226126</ArticleId><ArticleId IdType="pubmed">34178963</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Qiao D., Mann M., Garofalo R. P., Brasier A. R. (2020). Respiratory syncytial virus infection induces chromatin remodeling to activate growth factor and extracellular matrix secretion pathways. Viruses 12 (8), 804. doi: 10.3390/v12080804</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12080804</ArticleId><ArticleId IdType="pmc">PMC7472097</ArticleId><ArticleId IdType="pubmed">32722537</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye X., Zhang H. M., Qiu Y., Hanson P. J., Hemida M. G., Wei W., et al. . (2014). Coxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components. PloS Pathog. 10 (4), e1004070. doi: 10.1371/journal.ppat.1004070</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004070</ArticleId><ArticleId IdType="pmc">PMC3983067</ArticleId><ArticleId IdType="pubmed">24722419</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Chen B., Jiao A., Li F., Sun N., Zhang G., et al. . (2018). miR-663a inhibits tumor growth and invasion by regulating TGF-beta1 in hepatocellular carcinoma. BMC Cancer 18 (1), 1179. doi: 10.1186/s12885-018-5016-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-018-5016-z</ArticleId><ArticleId IdType="pmc">PMC6264054</ArticleId><ArticleId IdType="pubmed">30486878</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Huang Z., Huang M., Zeng J. (2020). Predicting severe enterovirus 71-infected hand, foot, and mouth disease: cytokines and chemokines. Mediators Inflammation 2020, 9273241. doi: 10.1155/2020/9273241</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/9273241</ArticleId><ArticleId IdType="pmc">PMC7013319</ArticleId><ArticleId IdType="pubmed">32089650</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M. Z., Guo X., Sun B., Sun X. F., Pang G. F., Yang L. Y., et al. . (2021). HA of H1N1 enhanced the expression of ICAM-1 and IL-6 in HUVECs and pathological injury in the lungs in mice. Gene 801, 145854. doi: 10.1016/j.gene.2021.145854</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2021.145854</ArticleId><ArticleId IdType="pmc">PMC8302257</ArticleId><ArticleId IdType="pubmed">34274468</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>